Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo

Immunity

Volumn 1, Issue 4, 1994, Pages 327-339

  Kearney, Elizabeth R ^a   Pape, Kathryn A ^a   Loh, Dennis Y ^b   Jenkins, Marc K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN RECEPTOR; OVALBUMIN; PEPTIDE; RECEPTORS, ANTIGEN, T CELL;

ADOPTIVE IMMUNOTHERAPY; ANIMAL; ARTICLE; BIOSYNTHESIS; CHICKEN; GENETICS; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MOUSE; MOUSE STRAIN; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMAL; ANTIGENS; CHICKENS; IMMUNE TOLERANCE; IMMUNIZATION; IMMUNIZATION, SECONDARY; IMMUNOTHERAPY, ADOPTIVE; IN VITRO; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OVALBUMIN; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0028466130     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/1074-7613(94)90084-1     Document Type: Article

References (54)

1. Peptide-induced T-cell tolerance to prevent autoimmune disease in a transgenic mouse model
2. Altered antigen receptor signaling in anergic T cells from self-tolerant T-cell receptor β-chain transgenic mice
3. Peripheral T-cell tolerance in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel D I
4. A modification of Jerne's theory of antibody production using the concept of clonal selection
5. In vivo role of IL-4 in T cell tolerance Induced by aqueous protein antigen
6. Kinetic differences in unresponsiveness of thymus and bone marrow cells
7. How B and T cells talk to each other
8. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
9. T cell receptor gene diversity and selection
10. The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of Thl but not Th2 lymphocytes
11. Effectiveness of lipid and lipidophilic substances as adjuvants
12. Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen
13. Small B cells as antigenpresenting cells in the induction of tolerance to soluble protein antigens
14. Murine 137-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and IL-2 production
15. Phagocytosis of the antigen, a crucial step in the induction of the primary response
16. B cells turn off virgin but not memory T cells
17. B-cell surface antigen 67 provides a costimulatory signal that induces T cells to proliferate and secrete IL-2
18. Non-Deletional Mechanisms of Peripheral and Central Tolerance: Studies with Transgenic Mice with Tissue-Specific Expression of a Foreign MHC Class I Antigen
19. The MHC-restricted antigen receptor on T cells. I. Isolation of a monoclonal antibody
20. The immune system evolved to discriminate infectious nonself from noninfectious self
21. In situ studies on the primary immune response to (4-hydroxy-3-nitrophenyl) acetyl. l. The architecture and dynamics of the responding populations
22. The role of cell division in the induction of clonal anergy
23. Antigen-presentation by chemically-modified splenocytes induces T cell unresponsiveness in vitro and in vivo
24. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells
25. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
26. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B
27. Specific immune regulation of chronic-relapsing experimental allergic encephalomyelitis in mice.
28. Antigen presentation by splenic B cells: resting B cells are ineffective whereas activated B cells are effective accessory cells for T cell responses
29. T cell immunity after viral infection versus T cell tolerance induced by soluble viral peptides
30. Intrathymic presentation of circulating non-MHC antigens
31. Migration and maturation of Langerhans cells in skin transplants and explants
32. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and IL-2 mRNA accumulation
33. Maturation and Dispersal of B-Cell Clones during T Cell-Dependent Antibody Responses
34. Stimulation with specific antigen can block superantigen-mediated deletion of T cells in vivo
35. The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells
36. Induction of immunological paralysis in two zones of dosage
37. Half-life of antigen/MHC class II complexes in vivo: intra- and interorgan variations
38. lo thymocytes in vivo
39. A form of immunologic tolerance through impairment of germinal center development
40. Immunological activity of covalently linked T-cell epitopes
41. Peripheral selection of the T cell repertoire
42. In vivo induction of tolerance in murine CD4' cell subsets
43. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-γ production
44. Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen
45. 51chromium
46. Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype
47. The dendritic cell system and its role in immunogenicity
48. Turnover of naive- and memoryphenotype T cells
49. + T cells is regulated by the antigenpresenting cell
50. Current status of immunological adjuvants
51. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity
52. Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis
53. QUANTITATIVE STUDIES ON THE MIXED LYMPHOCYTE INTERACTION IN RATS: V. TEMPO AND SPECIFICITY OF THE PROLIFERATIVE RESPONSE AND THE NUMBER OF REACTIVE CELLS FROM IMMUNIZED DONORS
54. B lymphoblastoid antigen (BB-1) expressed on EBV-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas